Cargando…
Comparison of Humoral Antibody Responses and Seroconversion Rates between Two Homologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination in Patients Undergoing Maintenance Hemodialysis
Background: Hemodialysis patients are at an increased risk of SARS-CoV-2 infection and are excluded from preauthorization COVID-19 vaccine trials; therefore, their immunogenicity is uncertain. Methods: To compare the antibody responses to homologous ChAdOx1 and mRNA-1273 SARS-CoV-2 vaccination in he...
Autores principales: | Hsiao, Shih-Hsin, Sue, Yuh-Mou, Kao, Chih-Chin, Chang, Hui-Wen, Lin, Yen-Chung, Hung, Ching-Sheng, Hsieh, Yi-Chen, Hong, Shiao-Ya, Chung, Chi-Li, Chang, Jer-Hwa, Su, Ying-Shih, Liu, Ming-Che, Lai, Kevin Shu-Leung, Chien, Ko-Ling, Wang, Jude Chu-Chun, Cheng, Chung-Yi, Fang, Te-Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383458/ https://www.ncbi.nlm.nih.gov/pubmed/37514977 http://dx.doi.org/10.3390/vaccines11071161 |
Ejemplares similares
-
The Humoral Immune Response of the ChAdOx1 nCoV-19 Vaccine in Maintenance Dialysis Patients without Prior COVID-19 Infection
por: Cheng, Chung-Yi, et al.
Publicado: (2022) -
Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan
por: Chang, Jer-Hwa, et al.
Publicado: (2022) -
SARS-CoV2 antibody response after a third dose of heterologous ChAdOx1 nCoV-19 and Moderna vaccine in chronic dialysis patients
por: Cheng, Chung-Yi, et al.
Publicado: (2022) -
Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination
por: Sheng, Wang-Huei, et al.
Publicado: (2022) -
Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination
por: Normark, Johan, et al.
Publicado: (2021)